statistiche ricercatore

Continente	#
NA - Nord America	749
AS - Asia	496
EU - Europa	462
Continente sconosciuto - Info sul continente non disponibili	49
SA - Sud America	46
AF - Africa	5
OC - Oceania	1
Totale	1.808

Nazione	#
US - Stati Uniti d'America	725
SG - Singapore	197
CN - Cina	119
UA - Ucraina	77
GB - Regno Unito	65
IE - Irlanda	58
SE - Svezia	55
IT - Italia	54
VN - Vietnam	50
RU - Federazione Russa	43
BR - Brasile	41
TR - Turchia	39
IN - India	38
FR - Francia	32
DE - Germania	29
BD - Bangladesh	24
FI - Finlandia	18
CZ - Repubblica Ceca	14
JP - Giappone	7
AT - Austria	5
CA - Canada	5
IQ - Iraq	5
ES - Italia	4
GT - Guatemala	4
HK - Hong Kong	3
JM - Giamaica	3
PK - Pakistan	3
TT - Trinidad e Tobago	3
AR - Argentina	2
CW - ???statistics.table.value.countryCode.CW???	2
ID - Indonesia	2
LT - Lituania	2
MX - Messico	2
MY - Malesia	2
NL - Olanda	2
PL - Polonia	2
PR - Porto Rico	2
SV - El Salvador	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
BB - Barbados	1
BE - Belgio	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EE - Estonia	1
ET - Etiopia	1
EU - Europa	1
GP - Guadalupe	1
IL - Israele	1
IR - Iran	1
KH - Cambogia	1
LB - Libano	1
MA - Marocco	1
NZ - Nuova Zelanda	1
PH - Filippine	1
PS - Palestinian Territory	1
TN - Tunisia	1
UY - Uruguay	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.763

Nome	#
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies	177
Acute urinary retention due to HSV-1: a case report	172
Metabolic modifications in HIV-infected women	162
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy	160
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.	146
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study.	136
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients.	132
Interruption of highly active antiretroviral therpy in HIV clinical practice.	131
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy.	129
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.	121
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina.	120
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection.	116
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis.	106
Totale	1.808

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	46	0	0	0	0	10	0	1	6	1	2	9	17
2022/2023	243	16	40	20	27	30	43	10	12	26	6	7	6
2023/2024	99	6	4	3	5	9	31	23	3	1	2	1	11
2024/2025	288	23	56	66	7	2	3	0	23	25	10	31	42
2025/2026	537	56	33	40	57	55	40	78	38	33	44	30	33
2026/2027	127	8	22	19	43	35	0	0	0	0	0	0	0
Totale													1.808